ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Fitness

Genetic factors associated with obesity could protect against diabetes

Washington D.C. [USA], Nov 3 (ANI): Genetic factors tied to obesity may protect us against diabetes, according to a University of Exeter study published in the journal- Diabetes.

ANI Nov 03, 2018 12:35 IST googleads

Representational Image

Washington D.C. [USA], Nov 3 (ANI): Genetic factors tied to obesity may protect us against diabetes, according to a University of Exeter study published in the journal- Diabetes.
Experts believe that the region in the body where surplus fat is stored matters more than the amount when it comes to insulin resistance, the risk of diabetes and other conditions.
Now, 14 new genetic variants that dictate where the body stores surplus fat have been pinpointed by scientists, and surprisingly, some genetic factors that increase obesity work to lower metabolic risk.
"Where fat is stored is more important in terms of diabetes risk or other consequences than the actual amount of fat," said Professor Alex Blakemore. "There are some genetic factors that increase obesity, but paradoxically reduce metabolic risk. It is to do with where on the body the fat is stored. Directly under the skin is better than around the organs or especially, within the liver."
The team looked at data from the UK biobank from more than 500,000 people aged between 37 and 73. They used MRI (magnetic resonance imaging) scans of these people's waists to match where they stored extra fat with whether they showed signs of Type 2 diabetes, heart attack and risk of stroke.
The researchers found 14 genetic variations or changes in DNA molecule linked with higher BMI (body mass index) but lower risk of diabetes, lower blood pressure and lower risk of heart disease. The study showed that as they gain weight, people who carry these genetic factors store it safely under the skin, and so have less fat in their major organs such as the liver, pancreas, and kidneys.
"There are many overweight or obese individuals who do not carry the expected metabolic disease risks associated with higher BMI," said Dr Hanieh Yaghootkar. "Meanwhile, some lean or normal weight individuals develop diseases like type 2 diabetes.
"Since a large proportion of many populations are overweight or obese, our findings will help understand the mechanisms that delay or protect overweight or obese individuals from developing adverse metabolic outcomes including type 2 diabetes, heart disease, and hypertension," he added. (ANI)

Get the App

What to Read Next

Others

Obesity linked to changed connection patterns with brain regions

Obesity linked to changed connection patterns with brain regions

According to a recent study, people who are obese exhibit hypo-connectivity with the left inferior frontal gyrus (related with cognitive control) and hyper-connectivity with a portion of the ventral occipitotemporal cortex

Read More
Food

Study finds how Pecans curb obesity, reduce inflammation

Study finds how Pecans curb obesity, reduce inflammation

Researchers discovered that pecans provide health benefits that may reduce inflammation and prevent obesity.

Read More
Food

How dietary restraint reduces effects of genetic risk of obesity

How dietary restraint reduces effects of genetic risk of obesity

According to new research, persons with obesity risk genes tend to feel more hungry and lose control over their eating, while practicing dietary restrictions may help to reverse this.

Read More
Food

Dietary restraint reduces effects of obesity risk: Study

Dietary restraint reduces effects of obesity risk: Study

Obesity risk genes cause people to feel hungrier and lose control of their eating, although practising dietary constraints may help to reverse this.

Read More
Fitness

Doses of oral semaglutide improve blood sugar, weight loss: Study

Doses of oral semaglutide improve blood sugar, weight loss: Study

Diabetes is a chronic condition that makes it difficult to regulate blood sugar levels. For many people, the condition worsens with time, making it harder to control blood sugar levels. Semaglutide is one example of a GLP-1 receptor agonist that has given patients more control over blood sugar lowering.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.